NASDAQ:DVAX
USD
9.39
- (-3.1%)
DYNAVAX TECHNOLOGIES CORPORATION
Industry: Drug Manufacturers - Specialty & Generic
End of Day: 9 May 2025 GMT-4
USD 9.390
- (-3.1%)
End of Day: 9 May 2025 GMT-4
Industry: Drug Manufacturers - Specialty & Generic
Quote
Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-
Company Info
more
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its cur...
Key Ratios
more
Income
more
Total Revenues (USD, MM)
-
Net Income (USD, MM)
-
Net Margin
-
Balance Sheet
more
Total Assets (USD, MM)
-
Total Liabilities (USD, MM)
-
Book Value Per Share
-
Cash Flow
more
Operations (USD, MM)
-
Investing (USD, MM)
-
Financing (USD, MM)
-
Make Smart Investment Choices